Inhibition of epidermal growth factor receptor signaling by saussurea involucrata, a rare traditional chinese medicinal herb, in human hormone-resistant prostate cancer PC-3 cells

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 6, 2010, Pages 3356-3365

  Way, Tzong Der ^a   Lee, Jang Chang ^b,c   Kuo, Daih Huang ^e   Fan, Ling Ling ^a   Huang, Chi Hung ^f   Lin, Hui Y I ^b   Shieh, P O Chuen ^e   Kuo, P O Tsun ^g   Liao, Chien F U ^d   Hanshi, Liu ^h   Kao, Jung Yie ^g  

^a Immunology and Biopharmaceutics   (Taiwan)

^b Department of Biological Science and Technology   (Taiwan)

^c Graduate Institute of Pharmaceutical Chemistry   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e TAJEN UNIVERSITY   (Taiwan)

^f Taiwan Advance Biopharm Inc   (Taiwan)

^g NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^h Dalian Practical Biotechnology Co   (China)

Author keywords

AKT; EGFR; Prostate cancer; Saussurea involucrata; STAT3

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HERBACEOUS AGENT; HORMONE; PLANT EXTRACT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; HUMAN; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PROSTATE TUMOR; SAUSSUREA; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; DOWN-REGULATION; DRUGS, CHINESE HERBAL; HORMONES; HUMANS; MALE; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SAUSSUREA; SIGNAL TRANSDUCTION;

SAUSSUREA; SAUSSUREA INVOLUCRATA;

EID: 77949787316     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf903793p     Document Type: Article

References (34)

1. Fu, L. G. China Plant Red Data Book-rare and Endangered Plants; Chinese Science Press: Beijing, 1992; Vol.1 [M], pp 234-235.
2. Li, J. S.; Cai, S. Q. Chemical constituents and pharmcological activity of eight species herb Xuelianhua. Chin. Pharm. J. 1998, 33, 449-452.
3. Smith, R. A.; Cokkinides, V.; Brawley, O. W. Cancer screening in the United States, 2009: A. review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J. Clin 2009, 59, 27-41.
4. Griffiths, K.; Eaton, C. L.; Harper, M. E.; Turkes, A.; Peeling, W. B. Hormonal treatment of advanced disease: Some newer aspects. Semin. Oncol. 1994, 21, 672-687.
5. Ciardiello, F. Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents. Drugs 2000, 60 (Suppl. 1), 25-32.
6. Yarden, Y.; Sliwkowski, M. X. Untangling the ErbB signaling network. Nat. Rev. Mol. Cell Biol. 2001, 2, 127-137.
7. Prenzel, N.; Fischer, O. M.; Streit, S.; Hart, S.; Ullrich, A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr. Relat. Cancer 2001, 8, 11-31.
8. Di Lorenzo, G..; Tortora, G.; D'Armiento, F. P.; De Rosa, G.; Staibano, S.; Autorino, R.; D'Armiento, M.; De Laurentiis, M.; De Placido, S.; Catalano, G.; Bianco, A. R.; Ciardiello, F. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin. Cancer Res. 2002, 8, 3438-3444.
9. Itoh, N.; Patel, U.; Skinner, M. K. Developmental and hormonal regulation of transforming growth factor-alpha and epidermal growth factor receptor gene expression in isolated prostatic epithelial, and stromal cells. Endocrinology 1998, 139, 1369-1377.
10. Festuccia, C.; Gravina, G. L.; Angelucci, A.; Millimaggi, D.; Muzi, P.; Vicentini, C.; Bologna, M. Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro. Int. J. Cancer 2005, 115, 630-640.
11. Vinals, F.; Chambard, J. C.; Pouyssegur, J. p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J. Biol. Chem. 1999, 274, 26776-26782.
12. Meloche, S.; Pouyssegur, J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007, 26, 3227-3239.
13. Polager, S.; Ginsberg, D. E2F-At the crossroads of life and death. Trends Cell Biol. 2008, 18, 528-535.
14. Harper, J. W.; Elledge, S. J.; Keyomarsi, K.; Dynlacht, B.; Tsai, L. H.; Zhang, P.; Dobrowolski, S.; Bai, C.; Connell-Crowley, L.; Swindell, E. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 1995, 6, 387-400.
15. Morgan, D. O. Principles of CDK regulation. Nature 1995, 374, 131-134.
16. Kuo, P. T.; Lin, T. P.; Liu, L. C.; Huang, C. H.; Lin, J. K.; Kao, J. Y.; Way, T. D. Penta-O-galloyl-β-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression. J. Agric. Food Chem. 2009, 57, 3331-3339.
17. Way, T. D.; Lin, H. Y.; Kuo, D. H.; Tsai, S. J.; Shieh, J. C.; Wu, J. C.; Lee, M. R.; Lin, J. K. Pu-erh tea attenuates hyperlipogenesis and induces hepatoma cells growth arrest through activating AMP-activated protein kinase (AMPK) in human HepG2 cells. J. Agric. Food Chem. 2009, 57, 5257-5264.
18. Li, P.; Nijhawan, D.; Wang, X. Mitochondrial activation of apoptosis. Cell 2004, 116 (Suppl. 2), S57-S59.
19. Fu, C. X.; Xu, Y. J.; Zhao, D. X.; Ma, F. S. A comparison between hairy root cultures and wild plants of Saussurea involucrata in phenylpropanoids production. Plant Cell Rep. 2006, 24, 750-754.
20. Li, Y.; Wang, C.; Guo, S.; Yang, J.;Xiao, P. Three guaianolides from Saussurea involucrata and their contents determination by HPLC. J. Pharm. Biomed. Anal. 2007, 44, 288-292.
21. Chiang, P. C.; Lin, S. C.; Pan, S. L.; Kuo, C. H.; Tsai, I. L.; Kuo, M. T.; Wen, W. C.; Chen, P.; Guh, J. H. Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: A crucial role of AMPK and mTOR pathways. Biochem. Pharmacol. 2010, 79, 162-171.
22. Li, Z. F.; Wang, Z. D.; Ji, Y. Y.; Zhang, S.; Huang, C.; Li, J.; Xia, X. M. Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract. World J. Gastroenterol. 2009, 15, 4538-4546.
23. Abbas, T.; Dutta, A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 2009, 9, 400-414.
24. Khan, N.; Afaq, F.; Mukhtar, H. Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis 2007, 28, 233-239.
25. Fesik, S. W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 2005, 5, 876-885.
26. Xiao, X.; Wu, J.; Zhu, X.; Zhao, P.; Zhou, J.; Liu, Q. Q.; Zheng, L.; Zeng, M.; Liu, R.; Huang, W. Induction of cell cycle arrest and apoptosis in human nasopharyngeal carcinoma cells by ZD6474, an inhibitor of VEGFR tyrosine kinase with additional activity against EGFR tyrosine kinase, Int. J. Cancer 2007, 121, 2095-2104.
27. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 2000, 103, 211-225.
28. Yarden, Y.; Sliwkowski, M. X. Untangling the erbB signaling network. Nat. Rev. Mol. Cell Biol. 2001, 2, 127-137.
29. Yu, H.; Jove, R. The STATs of cancer-New molecular targets come of age. Nat, Rev. Cancer 2004, 4, 97-105.
30. Hennessy, B. T.; Smith, D. L.; Ram, P. T.; Lu, Y.; Mills, G. B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discovery 2005, 4, 988-1004.
31. Lee, E. R.; Kang, Y. J.; Kim, J. H.; Lee, H. T.; Cho, S. G. Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J. Biol. Chem. 2005, 280, 31498-31507.
32. Park, J. I.; Strock, C. J.; Ball, D. W.; Nelkin, B. D. The Ras/Raf/ MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/ JAK/STAT pathway, Mol. Cell. Biol. 2003, 23, 543-554.
33. Moon, S. K.; Jung, S. Y.; Choi, Y. H.; Lee, Y. C.; Patterson, C.; Kim, C. H. PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: Involvement of p38 mitogen activated protein kinase. J. Cell. Physiol. 2004, 198, 310-323.
34. Lee, B; Kim, C. H.; Moon, S. K. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. FEBS Lett. 2006, 580, 5177-5184.